SCHEMBL19919641

SCHEMBL19919641

Cc1ccc(-c2ccc3c4ccc(-c5ccc(C)cc5)cc4n(-c4cc(-c5cc(C)nc(C)c5)c(-n5c6cc(-c7ccc(C)cc7)ccc6c6ccc(-c7ccc(C)cc7)cc65)cc4C#N)c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.36
MAOA P21397 6/20 0.36
MAOB P27338 5/20 0.36
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
GAA P10253 2/20 0.32
HPGD P15428 2/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
GLA P06280 1/20 0.32
CASP1 P29466 1/20 0.32
RECQL P46063 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913237 0.96 MAOA (0.34) ARMAOAMAOBKDM4EALDH1A1
SCHEMBL19919841 0.92 KDM5B (0.35) MAOAMAOBCYP11B1CYP11B2
SCHEMBL19909514 0.92 CYP1A2 (0.40) CYP11B1CYP11B2KDM4EALDH1A1HPGD
SCHEMBL19909097 0.92 CHEK1 (0.39) CYP11B2CHEK1
SCHEMBL19919834 0.92 AR (0.37) ARMAOAMAOBCYP11B1CYP11B2
SCHEMBL19913220 0.91 KDM4E (0.34) MAOAMAOBKDM4EALDH1A1GAA
SCHEMBL19909528 0.90 CYP1A2 (0.38) CYP11B1CYP11B2KDM4EALDH1A1HPGD
SCHEMBL19913239 0.90 AR (0.40) ARKDM4EALDH1A1GAAHPGD
SCHEMBL23487691 0.89 AR (0.36) ARMAOAMAOBCYP11B1CYP11B2
SCHEMBL19919838 0.89 MAOA (0.34) ARMAOAMAOBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 AR 4245/4885MAOA 401/4885MAOB 230/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 AR 4444/4885MAOA 715/4885MAOB 483/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 AR 4245/4885MAOA 401/4885MAOB 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.